Ignite Creation Date:
2024-05-06 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05096390
Status:
RECRUITING
Last Update Posted:
2024-01-25
First Post:
2021-10-14
Brief Title:
Axitinib - Pembrolizumab in First Line Treatment of mPRCC
Sponsor:
Centre Leon Berard
Organization:
Centre Leon Berard
Organization Data
Organization:
Centre Leon Berard
Class:
OTHER
Study ID:
PAXIPEM ET21-023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Leon Berard
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None